HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolonged complete remission after induction chemotherapy followed by chemoradiation with tomotherapy in metastatic nasopharyngeal cancer.

AbstractBACKGROUND:
Nasopharyngeal carcinoma (NPC) is uncommon in the Western hemisphere and in Europe. The undifferentiated subtype has a relevant propensity to metastasize systemically, mostly in the skeleton. In patients with distant metastasis at presentation there is no consensus on the most appropriate approach.
CASE REPORT:
Evaluation of a young patient with initially bony metastatic nasopharyngeal cancer treated with platinum-based induction chemotherapy followed by radiotherapy (performed with Tomotherapy) combined to chemotherapy on primary region with curative intent, and subsequent focal irradiation of the bone metastasis.
CONCLUSION:
After 27 months from the end of the planned treatment the patient has not shown any late toxicity or complications in the treated areas and is without any evidence of progression. It seems appropriate to treat selected metastatic patients with a radical intent, using induction chemotherapy followed by radical chemoradiotherapy on the primary region and high dose radiation on the metastasis. Moreover, Tomotherapy demonstrated a tolerable grade of acute toxicity without any relevant late complications.
AuthorsDario Agnese, Liliana Belgioia, Almalina Bacigalupo, Michela Marcenaro, Stefania Vecchio, Stefano Agostinelli, Silvia Morbelli, Renzo Corvò
JournalAnticancer research (Anticancer Res) Vol. 34 Issue 9 Pg. 5075-8 (Sep 2014) ISSN: 1791-7530 [Electronic] Greece
PMID25202093 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Topics
  • Carcinoma
  • Chemoradiotherapy
  • Humans
  • Induction Chemotherapy
  • Male
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms (diagnosis, pathology, therapy)
  • Neoplasm Metastasis
  • Radiotherapy, Intensity-Modulated
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: